MX2021009038A - Composiciones topicas de naproxeno en gel. - Google Patents
Composiciones topicas de naproxeno en gel.Info
- Publication number
- MX2021009038A MX2021009038A MX2021009038A MX2021009038A MX2021009038A MX 2021009038 A MX2021009038 A MX 2021009038A MX 2021009038 A MX2021009038 A MX 2021009038A MX 2021009038 A MX2021009038 A MX 2021009038A MX 2021009038 A MX2021009038 A MX 2021009038A
- Authority
- MX
- Mexico
- Prior art keywords
- naproxen
- gel compositions
- topical gel
- topical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente divulgación se relaciona en general con composiciones analgésicas tópicas que comprenden fármacos antiinflamatorios no esteroideos, y más específicamente con composiciones tópicas de naproxeno en gel en combinación con agentes neutralizantes selectos, que poseen por lo tanto propiedades mejoradas de permeación cutánea y de retención cutánea, así como también una estética mejorada tras la aplicación y el secado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962798352P | 2019-01-29 | 2019-01-29 | |
PCT/US2020/012654 WO2020159676A1 (en) | 2019-01-29 | 2020-01-08 | Topical gel compositions of naproxen |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021009038A true MX2021009038A (es) | 2021-08-16 |
Family
ID=69411579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021009038A MX2021009038A (es) | 2019-01-29 | 2020-01-08 | Composiciones topicas de naproxeno en gel. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220160667A1 (es) |
EP (1) | EP3917493A1 (es) |
AU (1) | AU2020216278A1 (es) |
BR (1) | BR112021012822A2 (es) |
CA (1) | CA3127881A1 (es) |
MX (1) | MX2021009038A (es) |
WO (1) | WO2020159676A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023091796A1 (en) * | 2021-11-22 | 2023-05-25 | Arizona Board Of Regents On Behalf Of Arizona State University | Solutions and gels of one-dimensional metal oxides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR6915470D0 (pt) * | 1969-03-24 | 1973-03-13 | Syntex Corp | Processo para preparar derivados de acido 2-(6'substituido 2'naftil)propionico e de seus sais |
CA2232855C (en) * | 1997-04-10 | 2007-10-09 | Roche Consumer Health (Worldwide) Sa | Pharmaceutical formulation |
CA2371836C (en) * | 1999-05-27 | 2006-01-31 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US20100099766A1 (en) * | 2008-10-16 | 2010-04-22 | Novartis Ag | Topical NSAID compositions having sensate component |
US20110052679A1 (en) * | 2009-08-25 | 2011-03-03 | Pharmaceutics International, Inc. | Solid naproxen concentrates and related dosage forms |
-
2020
- 2020-01-08 EP EP20703127.9A patent/EP3917493A1/en active Pending
- 2020-01-08 AU AU2020216278A patent/AU2020216278A1/en active Pending
- 2020-01-08 CA CA3127881A patent/CA3127881A1/en active Pending
- 2020-01-08 US US17/425,746 patent/US20220160667A1/en active Pending
- 2020-01-08 MX MX2021009038A patent/MX2021009038A/es unknown
- 2020-01-08 BR BR112021012822A patent/BR112021012822A2/pt unknown
- 2020-01-08 WO PCT/US2020/012654 patent/WO2020159676A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2020216278A1 (en) | 2021-07-15 |
WO2020159676A1 (en) | 2020-08-06 |
CA3127881A1 (en) | 2020-08-06 |
EP3917493A1 (en) | 2021-12-08 |
US20220160667A1 (en) | 2022-05-26 |
BR112021012822A2 (pt) | 2021-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4062900A3 (en) | Skin care cosmetic composition | |
MX2019010757A (es) | Métodos y composiciones relacionados con el tratamiento combinado con antiinflamatorios y nanoportadores sintéticos que comprenden un inmunosupresor. | |
BR112015027281A8 (pt) | usos de uma população de nanocarreadores sintéticos que são fixados a imunossupressores e composição compreendendo a referida população de nanocarreadores | |
CA2900335C (en) | Synthetic analogs of epipolythiodioxopiperazines and uses thereof | |
MX2014001318A (es) | Composiciones para el cuidado de la piel que contienen combinaciones de ingredientes naturales. | |
MX2017014253A (es) | Metodos y composiciones para promover el crecimiento del cabello. | |
MX2010004613A (es) | Composicion topica. | |
MX2015003239A (es) | Composiciones topicas y metodos de uso. | |
BR112018004644A2 (pt) | processo para alisamento semipermanente e modelagem permanente do cabelo | |
BR112016007462A2 (pt) | fitonutrientes anti-inflamatórios para uso no tratamento ou prevenção de sinovite | |
MX2018007871A (es) | Composiciones para el cuidado personal. | |
PH12019502874A1 (en) | Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments | |
EA201291295A1 (ru) | Высокоувлажняющая высокодисперсная эмульсия | |
CN113038946A8 (zh) | 用生物素组合物治疗自闭症和自闭症谱系障碍 | |
WO2019043176A3 (en) | HISTONE-DEACETYLASE INHIBITOR IN COMBINATION WITH ANTIMETABOLITE AGENT FOR CANCER THERAPY | |
SA518400042B1 (ar) | مترافق من فيناستيريد مع ببتيد | |
MX2021009038A (es) | Composiciones topicas de naproxeno en gel. | |
CY1116077T1 (el) | Τοπικες συνθεσεις για την προληψη σεξουαλικα μεταδιδομενων ασθενειων και μεθοδοι για την παραγωγη αυτων | |
PH12019500345A1 (en) | Conjugate of minoxidil and peptide | |
BR112015012960A2 (pt) | gel oral para o alívio da dor de dente | |
WO2018094023A3 (en) | Cyclic dipeptides and wound healing | |
WO2018105941A3 (ko) | 탈모방지 또는 발모촉진용 주사용 조성물 | |
WO2018111042A3 (ko) | 한약재 추출물을 유효성분으로 포함하는 화장료 조성물 | |
GEP201706743B (en) | Oral formulation for the treatment of cardiovascular diseases | |
BR112019001799A2 (pt) | composições para cuidados pessoais, processo para preparar uma composição e método não terapêutico para reduzir ou prevenir inflamação |